Showing results (2551-2560 of 2,674) with videos related to

Sort By:
Pageof 268
Contemporary Clinical Trials|September 20, 2021
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapseBhavna Oza, Eleni Frangou, Ben Smith, et al.
European Urology|February 3, 2026
Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)Dickon Hayne, Alison Y Zhang, Hayley Thomas, et al.
Science Advances|September 11, 2024
Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugsYunjung Jin, Fuyao Li, Zonghua Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Neuroimage|May 11, 2019
Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participantsNikita Nogovitsyn, Roberto Souza, Meghan Muller, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
The British Journal of Dermatology|March 10, 2019
Conjunctivitis in dupilumab clinical trialsB Akinlade, E Guttman-Yassky, M de Bruin-Weller, et al.
ACS Chemical Neuroscience|October 18, 2016
Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of DepressionAndrew P Degnan, George O Tora, Hong Huang, et al.
Acta Neuropathologica|August 4, 2021
Evidence of disrupted rhombic lip development in the pathogenesis of Dandy-Walker malformationParthiv Haldipur, Silvia Bernardo, Kimberly A Aldinger, et al.
Pageof 268